Vitamin D reduces PCOS (typically 50,000 IU weekly or bi-weekly) -Review March 2026

The Association Between Vitamin D and Polycystic Ovary Syndrome (PCOS) in Women: A Systematic Review

Nutrients Volume 18 Issue 6 10.3390/nu18060968

Lebanon

Background/Objectives: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by reproductive and metabolic dysfunction. Vitamin D deficiency is common in women with PCOS and is linked to adverse metabolic and reproductive outcomes. However, the role of vitamin D supplementation in managing PCOS remains unclear due to the heterogeneous evidence available. This systematic review aimed to synthesize both observational and interventional studies to assess the association between vitamin D levels and PCOS, focusing on prevalence, metabolic outcomes, and reproductive parameters.

Methods: A comprehensive search of PubMed, Web of Science, Scopus, and Embase was conducted in October 2025, identifying studies published between January 2000 and October 2025. Eligible studies included observational studies and randomized controlled trials (RCTs) evaluating serum 25-hydroxyvitamin D [25(OH)D] levels and/or the effects of vitamin D supplementation in women with PCOS. Studies were included if they used recognized diagnostic criteria for PCOS or sufficient diagnostic details to confirm the condition. Two reviewers independently performed screening, data extraction, and quality assessment according to PRISMA 2020 guidelines.

Results: Eleven studies (nine RCTs, two observational) encompassing 1063 women with PCOS met the inclusion criteria. Observational studies demonstrated inverse associations between serum 25(OH)D levels and insulin resistance, body mass index (BMI), and leptin, but not with total testosterone. RCTs showed modest and inconsistent improvements in insulin sensitivity, with effects more apparent in some trials enrolling vitamin D-deficient women. Reproductive benefits (cycle regularity/ovulation) were observed only in selected trials, generally with small samples and short follow-up.

Conclusions: Vitamin D deficiency is common in women with PCOS and correlates with metabolic and reproductive dysfunction. While vitamin D supplementation shows variable effects, it should not be considered a stand-alone therapy for PCOS. Correction of deficiency may complement existing treatments, but evidence remains insufficient to support routine vitamin D supplementation for fertility outcomes in PCOS.

PDF

PCOS CLAUDE AI March 2026

What it is: PCOS is one of the most common hormonal disorders in people with ovaries, affecting roughly 8–13% of reproductive-age women worldwide. Despite the name, not everyone with PCOS has cysts — the name comes from the appearance of multiple small follicles on ultrasound.

Core Features

PCOS is defined by a combination of three criteria (the "Rotterdam criteria"), with diagnosis requiring at least two of three:

Irregular or absent ovulation — infrequent or unpredictable menstrual cycles
Hyperandrogenism — elevated male hormones (androgens), causing acne, excess facial/body hair (hirsutism), or scalp hair thinning
Polycystic ovaries — ovaries with 12+ small follicles visible on ultrasound

Root Causes

The exact cause isn't fully understood, but key mechanisms include:

Insulin resistance — present in ~70% of cases; the pancreas overproduces insulin, which stimulates the ovaries to produce excess androgens
Hormonal dysregulation — elevated LH (luteinizing hormone) relative to FSH disrupts normal follicle development and ovulation
Chronic low-grade inflammation — appears to stimulate androgen production
Genetics — strong familial clustering; likely polygenic

Symptoms

Symptoms vary widely in type and severity:

Irregular, infrequent, or absent periods
Acne, oily skin
Excess hair growth on face, chest, or back
Hair loss or thinning on the scalp
Weight gain, especially abdominal
Difficulty conceiving (one of the leading causes of female infertility)
Mood changes, anxiety, depression
Darkened skin patches (acanthosis nigricans) — a sign of insulin resistance

Associated Health Risks

PCOS carries significant long-term metabolic and cardiovascular implications:

Type 2 diabetes — risk is 3–7× higher
Metabolic syndrome — hypertension, dyslipidemia, abdominal obesity
Endometrial cancer — from chronic anovulation and unopposed estrogen
Sleep apnea — more common than in the general population
Cardiovascular disease — elevated risk, though lifetime data are still emerging
Mental health — substantially elevated rates of depression and anxiety

Diagnosis

There is no single definitive test. Diagnosis involves:

Menstrual history and symptom review
Blood tests: androgens (testosterone, DHEAS), LH/FSH ratio, fasting insulin/glucose, lipid panel
Pelvic ultrasound
Ruling out other causes (thyroid disease, congenital adrenal hyperplasia, hyperprolactinemia)

Treatment

There's no cure; management targets specific symptoms and risk reduction:

Goal	Approach
Regulate cycles	Combined oral contraceptives (most common)
Reduce androgens	Birth control pills, spironolactone
Improve insulin sensitivity	Metformin, lifestyle changes
Fertility	Letrozole or clomiphene (ovulation induction)
Weight management	Diet, exercise — even 5–10% weight loss significantly improves symptoms
Mental health	Counseling, medication if needed

Lifestyle intervention — particularly low-glycemic diet and regular exercise — is considered first-line for most patients, especially those with insulin resistance.

Vitamin D Connection

Relevant to your work: vitamin D deficiency is highly prevalent in PCOS and correlates with worse insulin resistance, androgen levels, and menstrual irregularity. Several trials show that vitamin D supplementation improves insulin sensitivity, reduces androgen markers, and may partially restore ovulatory cycles — though it's not yet a standard-of-care recommendation.

Bottom line

PCOS is a heterogeneous syndrome sitting at the intersection of reproductive, metabolic, and endocrine dysfunction. Its variability makes it underdiagnosed, and its long-term metabolic risks are frequently undertreated. Early lifestyle and hormonal intervention can substantially reduce downstream complications.